Recent Updates
Recently added Catalysts
OABI Positive Sentiment

OmniAb to Host Investor & Analyst Day on October 6, 2026

Monday, September 14, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: OmniAb, Inc. has announced its Investor & Analyst Day scheduled for October 6, 2026, in Emeryville, CA. The event will include presentations from the company's executive leadership team, covering corporate updates and technology innovations. Attendees can expect insights into select partner programs and a Q&A session.

Market Sentiment Analysis

POSITIVE FACTORS

  • OmniAb is hosting an Investor & Analyst Day, indicating growth.
  • The event will feature presentations from the executive leadership team.
  • Focus on technology innovations and partner programs showcases progress.

Full Press Release Details

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #Antibody--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reiterates details of its upcoming Investor & Analyst Day, to be held on October 6, 2026, in Emeryville, CA. The event will feature presentations from OmniAb’s executive leadership team, including corporate updates, select partner programs, the xPloration® platform, technology innovations and a Q&A sessi

Frequently Asked Questions

When is OmniAb's Investor & Analyst Day?

The Investor & Analyst Day is scheduled for October 6, 2026.

Where will the OmniAb event take place?

The event will be held in Emeryville, California.

Who will present at the OmniAb event?

Presentations will be made by OmniAb's executive leadership team.

What topics will be covered at the Investor Day?

Topics include corporate updates, partner programs, and technology innovations.

ShareAdd on Google
Tags: OABI Viatris Investor Conferences Healthcare OmniAb Investor Day Emeryville biopharma
Last updated: Sep 14, 2026

Biotech snapshot

Cash runway
$52M liquidity · $0M/mo burn
Low dilution risk